2
Total Mentions
2
Documents
0
Connected Entities
Organization referenced in documents
EFTA00599823
USAC 6,000 Usa Compression Partners Lp USD Industrial 0.00% ($108.000) 5106.260 15..lan.13 18.00 17.71 (51.740) 16-Ian.13 ALNY 2,400 Alnylam Pharmaceuticals Inc USD snstoner. Nowt-cyclic 0.00% ($48,312) $50,040 16..lan.13 20.13 20.85 $1,728 16-Ian.13 ITMN 6,600 Intermune Inc USD snstoner. Nowt-
EFTA02714282
es to targeted disease tissues and cells. The Company is lead drug partner with Quark & Pfizer and is on Phase I for PKN3-targeted cancer siRNA. • Alnylam Pharmaceuticals Inc (ALNY US) — is an early stage therapeutics company. The Company is developing technology that can specifically and potently silence disease-causing
No connected entities